ENT Outpatient ConditionsNCT07914543
Drug Utilization and Prescribing Practices in the ENT Outpatient Department
An observational study of ENT Outpatient Conditions, run by AlFayhaa General Hospital at 2 sites in Iraq.
Trial summary
This cross-sectional, observational study evaluates drug utilization patterns and prescribing practices in the ear, nose, and throat (ENT) outpatient department using World Health Organization (WHO) core prescribing indicators. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- ENT Outpatient Conditions
- How many people
- 600 participants
- Where
- 2 sitesIraq
- Study dates
- 15 Oct 2026to 15 Aug 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: All patients of any age group attending the Ear, Nose, and Throat (ENT) outpatient department and receiving at least one medical prescription during the study period.
Who may be able to join
- Patients attending the ENT outpatient department during the study period.
- Patients receiving at least one prescription.
- Patients of all age groups.
Who cannot join
- Incomplete prescriptions.
- Inpatients (admitted patients).
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Iraq2 sites
Al-Mawanee Teaching Hospital
Basra, Basra Governorate
AL-Hassan M Almudafeer, +9647801601693
Al-Mawanee Teaching Hospital
Basra
Alhasan Al-mudafeer, +9647801601693
About this study
Official title: Drug Utilization Patterns and Evaluation of Prescribing Practices Using WHO Prescribing Indicators in the ENT Outpatient Department
This cross-sectional, observational study evaluates drug utilization patterns and prescribing practices in the ear, nose, and throat (ENT) outpatient department using World Health Organization (WHO) core prescribing indicators. The study aims to assess prescription quality, the average number of drugs per encounter, antibiotic overuse, generic prescribing rates, and adherence to essential medicines lists to promote rational drug use and identify potential polypharmacy trends.
- Conditions
- ENT Outpatient Conditions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| ENT Outpatient Prescriptions | Prescriptions issued to patients attending the ear, nose, and throat (ENT) outpatient department during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Average Number of Drugs Per Prescription
Assessment of the average number of medications prescribed per patient encounter in the ENT outpatient department using WHO prescribing indicators.
Measured: During the 4-6 month study period
Secondary outcomes (3)
Percentage of Encounters with Antibiotics
To calculate the percentage of patient encounters where at least one antibiotic is prescribed in the ENT outpatient department.
Measured: During the 4-6 month study period
Percentage of Drugs Prescribed by Generic Name
To assess the extent of generic prescribing relative to total drugs prescribed in the ENT outpatient department.
Measured: During the 4-6 month study period
Adherence to Essential Medicines List
To evaluate whether the prescribed medications are selected from the official essential medicines list.
Measured: During the 4-6 month study period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Nov 2026
- Study start15 Oct 2026 (estimated)
- Primary completion15 Apr 2027 (estimated)
- Study completion15 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ENT Outpatient ConditionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- AlFayhaa General Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alhasan Mujtaba Al-Mudhaffer, AlFayhaa General Hospital
- Investigators
- Alhasan M Al-mudafeer, Principal investigator, AlFayhaa General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07914543
- Sponsor's protocol ID
- ENTWHO-2026-01
- Status last verified
- Oct 2026
- First submitted
- 28 Oct 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Drug Utilization Patterns and Evaluation of Prescribing Practices Using WHO Prescribing Indicators in the ENT Outpatient Department
- ClinicalTrials.gov ID
- NCT07914543
- Acronym / sponsor ID
- ENTWHO-2026-01
- Conditions
- ENT Outpatient Conditions
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- AlFayhaa General HospitalUniversity, hospital or other
- Study start
- 15 Oct 2026 (estimated)
- Primary completion
- 15 Apr 2027 (estimated)
- Study completion
- 15 Aug 2027 (estimated)
- First posted
- 3 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cross-sectional, observational study evaluates drug utilization patterns and prescribing practices in the ear, nose, and throat (ENT) outpatient department using World Health Organization (WHO) core prescribing indicators. The study aims to assess prescription quality, the average number of drugs per encounter, antibiotic overuse, generic prescribing rates, and adherence to essential medicines lists to promote rational drug use and identify potential polypharmacy trends.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ENT Outpatient Prescriptions | – | –Prescriptions issued to patients attending the ear, nose, and throat (ENT) outpatient department during the study period. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients of any age group attending the Ear, Nose, and Throat (ENT) outpatient department and receiving at least one medical prescription during the study period.
Key inclusion criteria (3 listed)
- Patients attending the ENT outpatient department during the study period.
- Patients receiving at least one prescription.
- Patients of all age groups.
Key exclusion criteria (2 listed)
- Incomplete prescriptions.
- Inpatients (admitted patients).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Average Number of Drugs Per Prescription
Time frame: During the 4-6 month study period
Assessment of the average number of medications prescribed per patient encounter in the ENT outpatient department using WHO prescribing indicators.
3 secondary outcomes
Percentage of Encounters with Antibiotics
Time frame: During the 4-6 month study period
Percentage of Drugs Prescribed by Generic Name
Time frame: During the 4-6 month study period
Adherence to Essential Medicines List
Time frame: During the 4-6 month study period
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Alhasan M Al-mudafeer principal investigator
AlFayhaa General Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ENT Outpatient Conditions, run by AlFayhaa General Hospital at 2 sites in Iraq.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shams A Kadhim (+9647738645300, 97shamsali@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Average Number of Drugs Per Prescription (time frame: During the 4-6 month study period). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.